Biotech Values

[DewDiligence]

Several XON insiders recently bought stock on the open market; CEO Randall Kirk bought ~$1M worth on 5/9/13-/5/13/13 (see first link below):

http://www.sec.gov/Archives/edgar/data/1091823/000114036114020588/xslF345X03/doc1.xml

http://www.sec.gov/Archives/edgar/data/1298709/000149890214000058/xslF345X03/edgar.xml

http://www.sec.gov/Archives/edgar/data/1298711/000149890214000059/xslF345X03/edgar.xml

http://www.sec.gov/Archives/edgar/data/1356090/000149890214000057/xslF345X03/edgar.xml

http://www.sec.gov/Archives/edgar/data/1356090/000149890214000056/xslF345X03/edgar.xml

http://www.sec.gov/Archives/edgar/data/1356090/000149890214000060/xslF345X03/edgar.xml

http://www.sec.gov/Archives/edgar/data/1356090/000149890214000062/xslF345X03/edgar.xml

The last few transactions above were tokens (especially the 640-share purchase by the CSO); however, the aggregate amount of all the buys was about $1.8M. These buys are in addition to the $2.6M purchase by an SVP in Feb-Mar 2014 (http://www.sec.gov/Archives/edgar/data/1283518/000149890214000023/xslF345X03/edgar.xml ).